Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
China
· Delayed Price · Currency is CNY 3.250
+0.030 (0.93%)
Apr 29, 2026, 3:04 PM CST
SHE:002589 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Cash & Equivalents | 5,050 | 3,745 | 4,984 | 5,061 | 5,340 | 4,579 | Upgrade
|
| Cash & Short-Term Investments | 5,050 | 3,745 | 4,984 | 5,061 | 5,340 | 4,579 | Upgrade
|
| Cash Growth | 1.51% | -24.86% | -1.52% | -5.23% | 16.63% | -20.97% | Upgrade
|
| Accounts Receivable | 4,041 | 4,176 | 4,375 | 4,222 | 4,603 | 11,276 | Upgrade
|
| Other Receivables | 703.3 | 717.08 | 892.75 | 990.01 | 1,670 | 1,897 | Upgrade
|
| Receivables | 4,745 | 4,893 | 5,268 | 5,212 | 6,274 | 13,172 | Upgrade
|
| Inventory | 651.64 | 715.3 | 734.74 | 1,119 | 954.51 | 2,068 | Upgrade
|
| Prepaid Expenses | - | - | 0 | 0.11 | - | 7.27 | Upgrade
|
| Other Current Assets | 158.7 | 100.42 | 94.88 | 147.07 | 250.97 | 845.88 | Upgrade
|
| Total Current Assets | 10,605 | 9,453 | 11,081 | 11,539 | 12,820 | 20,672 | Upgrade
|
| Property, Plant & Equipment | 2,015 | 2,018 | 2,238 | 2,277 | 2,297 | 2,527 | Upgrade
|
| Long-Term Investments | 921.33 | 821.33 | 746.72 | 852.03 | 594.07 | 805.82 | Upgrade
|
| Goodwill | 146.67 | 146.67 | 146.67 | 146.67 | 146.69 | 620.27 | Upgrade
|
| Other Intangible Assets | 482.79 | 506.7 | 440.89 | 552.39 | 624.21 | 478.35 | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | - | - | 0.07 | Upgrade
|
| Long-Term Deferred Tax Assets | 317.38 | 321.59 | 286.15 | 284.44 | 106.68 | 122.86 | Upgrade
|
| Long-Term Deferred Charges | 48.09 | 49.69 | 39.16 | 60.87 | 89.93 | 134.58 | Upgrade
|
| Other Long-Term Assets | 1,011 | 1,053 | 1,033 | 996.39 | 1,654 | 1,035 | Upgrade
|
| Total Assets | 15,547 | 14,370 | 16,012 | 16,709 | 18,332 | 26,397 | Upgrade
|
| Accounts Payable | 4,580 | 3,760 | 3,382 | 3,723 | 7,715 | 9,791 | Upgrade
|
| Accrued Expenses | 14.86 | 17.71 | 42.21 | 66.98 | 57.68 | 227.5 | Upgrade
|
| Short-Term Debt | 4,612 | 4,201 | 6,092 | 6,556 | 3,926 | 4,440 | Upgrade
|
| Current Portion of Long-Term Debt | 27.53 | 168.69 | 155.38 | 5.6 | 6.51 | 6.3 | Upgrade
|
| Current Portion of Leases | - | - | 0.76 | 0.52 | 1.82 | 10.09 | Upgrade
|
| Current Income Taxes Payable | 13.62 | 21.75 | 3.62 | 1.68 | 5 | 91.82 | Upgrade
|
| Current Unearned Revenue | 14.99 | 9.44 | 25.13 | 29.12 | 32.43 | 174.72 | Upgrade
|
| Other Current Liabilities | 392.47 | 483.6 | 232.26 | 378.53 | 724.46 | 1,766 | Upgrade
|
| Total Current Liabilities | 9,656 | 8,662 | 9,933 | 10,761 | 12,468 | 16,508 | Upgrade
|
| Long-Term Debt | 397.86 | 234.71 | 327.08 | 261.27 | 67.2 | 48.5 | Upgrade
|
| Long-Term Leases | 1.52 | 0.93 | 4.12 | 0.84 | 2.73 | 39.19 | Upgrade
|
| Long-Term Unearned Revenue | 4.53 | 4.57 | 4.74 | 1.62 | 1.93 | 17.5 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 41.89 | 44.96 | 48.5 | 47.48 | 40.58 | 83.56 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 7.28 | Upgrade
|
| Total Liabilities | 10,102 | 8,947 | 10,318 | 11,072 | 12,581 | 16,704 | Upgrade
|
| Common Stock | 1,505 | 1,505 | 1,505 | 1,505 | 1,505 | 1,505 | Upgrade
|
| Additional Paid-In Capital | 3,483 | 3,477 | 3,589 | 3,720 | 3,701 | 4,015 | Upgrade
|
| Retained Earnings | 429.96 | 419.59 | 444.35 | 453.83 | 432.66 | 2,278 | Upgrade
|
| Treasury Stock | -101.48 | -101.48 | - | -230.65 | -230.65 | -230.65 | Upgrade
|
| Total Common Equity | 5,316 | 5,300 | 5,538 | 5,448 | 5,407 | 7,567 | Upgrade
|
| Minority Interest | 128.36 | 123.11 | 156.83 | 189.18 | 344 | 2,126 | Upgrade
|
| Shareholders' Equity | 5,445 | 5,423 | 5,695 | 5,637 | 5,751 | 9,693 | Upgrade
|
| Total Liabilities & Equity | 15,547 | 14,370 | 16,012 | 16,709 | 18,332 | 26,397 | Upgrade
|
| Total Debt | 5,039 | 4,605 | 6,579 | 6,824 | 4,004 | 4,544 | Upgrade
|
| Net Cash (Debt) | 10.8 | -860.3 | -1,595 | -1,764 | 1,336 | 34.82 | Upgrade
|
| Net Cash Growth | - | - | - | - | 3737.34% | - | Upgrade
|
| Net Cash Per Share | 0.01 | -0.54 | -1.06 | -1.17 | 0.90 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 1,503 | 1,933 | 1,505 | 1,496 | 1,496 | 1,496 | Upgrade
|
| Total Common Shares Outstanding | 1,503 | 1,933 | 1,505 | 1,496 | 1,496 | 1,496 | Upgrade
|
| Working Capital | 948.8 | 791.18 | 1,148 | 777.98 | 351.12 | 4,164 | Upgrade
|
| Book Value Per Share | 3.54 | 2.74 | 3.68 | 3.64 | 3.61 | 5.06 | Upgrade
|
| Tangible Book Value | 4,687 | 4,646 | 4,950 | 4,749 | 4,636 | 6,468 | Upgrade
|
| Tangible Book Value Per Share | 3.12 | 2.40 | 3.29 | 3.17 | 3.10 | 4.32 | Upgrade
|
| Buildings | - | - | 1,974 | 1,819 | 1,865 | 1,468 | Upgrade
|
| Machinery | - | - | 686.13 | 695.38 | 778.65 | 1,436 | Upgrade
|
| Construction In Progress | 307.39 | - | 307.34 | 429.34 | 315.37 | 549.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.